Literature DB >> 19353840

Radiation-induced osteosarcoma with a rhabdomyosarcoma component arising from the dura mater: a case report.

S Utsuki1, H Oka, K Sato, S Shimizu, S Suzuki, K Fujii.   

Abstract

OBJECTIVE: Radiation-induced tumors are a rare complication of radiation therapy. Here, we describe the first case of a radiation-induced osteosarcoma with a rhabdomyosarcoma component arising from the dura mater after radiation therapy for an astrocytoma. PATIENT: An 18-year-old man with generalized seizures presented with a neoplastic lesion in the dura mater of a previously irradiated (56 Gy) region 5 years after the initial radiation therapy. A tumor resection was performed, and histological examination revealed an osteosarcoma with a rhabdomyosarcoma component. The tumor recurred despite eight tumorectomies and the addition of chemotherapy and radiotherapy. The patient died from tumor progression 5 years after the first surgical removal of the radiation-induced tumor.
CONCLUSION: This radiation-induced tumor may have originated from primitive, multipotent mesenchymal cells, as it included both osteosarcoma and rhabdomyosarcoma components.

Entities:  

Mesh:

Year:  2009        PMID: 19353840     DOI: 10.5414/npp28096

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  3 in total

1.  Cranial Ewing's sarcoma in children.

Authors:  Maria Moschovi; George A Alexiou; Natalia Tourkantoni; Mirsini-Ersi Balafouta; Christos Antypas; Maria Tsiotra; George Sfakianos; Neofytos Prodromou
Journal:  Neurol Sci       Date:  2011-03-02       Impact factor: 3.307

Review 2.  Meningeal chondroblastic osteosarcoma: case report and review of the literature.

Authors:  Emilie Romeo; Olivier Gisserot; Jean-Pierre de Jaureguiberry; Nicolas Desse; Jean-Baptiste Souraud; Naji Salem; Anthony Faivre; Corinne Bouvier; François Bertucci
Journal:  J Neurooncol       Date:  2010-04-30       Impact factor: 4.130

3.  Delayed development of a rhabdomyosarcoma following radiation for a spinal cord glioma.

Authors:  Edmond Marzbani; Edmond Mazbani; Robin L Jones; James Fink; Marc C Chamberlain
Journal:  J Neurooncol       Date:  2013-01-08       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.